Orthofix International NV shares plummeted 5.01% during Tuesday's intraday trading session, as the medical device maker's disappointing fourth-quarter earnings report weighed heavily on investor sentiment.
For the quarter ended December 2024, Orthofix reported earnings per share of $0.02, missing the consensus estimate of $0.06 per share. However, the company's revenue of $215.66 million surpassed expectations of $212.63 million. The earnings miss was a major disappointment for investors, despite the revenue beat.
Looking ahead, Orthofix expects full-year revenue for 2025 to range between $818 million and $826 million. Investors will closely monitor the company's performance and guidance in the coming quarters to assess its ability to regain profitability and deliver consistent earnings growth.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.